There is 1 paper on cumulative normalized creatinine-to-cystatin C ratio in aging research: 1 observational study in people.
1 paper studies it2 findings
1 new paper in 30 daysSee all 1 papers on cumulative normalized creatinine-to-cystatin C ratio
“Higher cumNCCR was associated with lower CVD risk (per SD: HR 0.83, 95% CI 0.74–0.93; P=0.002)”
- Humans1
Associations
1Incident cardiovascular disease
downin humans2HR 0.83–0.84
2 studies
Incident cardiovascular disease
downin humans2HR 0.83–0.84
Cumulative normalized creatinine-to-cystatin C ratio is associated with incident cardiovascular disease in humans (CKM stage 0–3, free of baseline CVD, eGFR >30 mL/min/1.73 m2) (Per SD: HR 0.83, 95% CI 0.74–0.93).
“Higher cumNCCR was associated with lower CVD risk (per SD: HR 0.83, 95% CI 0.74–0.93; P=0.002)”
HumansCKM stage 0–3, free of baseline CVD, eGFR >30 mL/min/1.73 m2per SDCumulative exposure: 2011–2015; follow-up: 2018/2020n = 3,222
ESC Congress 2026 abstract
Cumulative normalized creatinine-to-cystatin C ratio is associated with incident cardiovascular disease in humans (Chinese adults with metabolic dysfunction-associated steatotic liver disease) (16% lower CVD risk per 10-unit increase; HR 0.84, 95% CI 0.76–0.94).
“higher cumulative NCCR exposure was independently associated with a 16% lower risk of incident CVD per 10-units increase”
HumansChinese adults with metabolic dysfunction-associated steatotic liver diseaseMedian 7.77-year follow-upn = 1,428
BMC cardiovascular disorders